Manulife (Manufacturers Life Insurance)
RCKT icon

Manulife (Manufacturers Life Insurance)’s Rocket Pharmaceuticals RCKT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Sell
149,204
-3,917
-3% -$15.6K ﹤0.01% 2129
2025
Q4 		$526K Sell
153,121
-3,517
-2% -$12K ﹤0.01% 2154
2025
Q3 		$511K Sell
156,638
-19,065
-11% -$60K ﹤0.01% 2198
2025
Q2 		$430K Buy
175,703
+21,016
+14% +$106K ﹤0.01% 2237
2025
Q1 		$1.03M Buy
154,687
+2,198
+1% +$21.7K ﹤0.01% 1796
2024
Q4 		$1.92M Buy
152,489
+196
+0.1% +$2.95K ﹤0.01% 1582
2024
Q3 		$2.81M Buy
152,293
+12,680
+9% +$260K ﹤0.01% 1431
2024
Q2 		$3.01M Buy
139,613
+26,556
+23% +$610K ﹤0.01% 1357
2024
Q1 		$3.05M Buy
113,057
+12,121
+12% +$344K ﹤0.01% 1364
2023
Q4 		$3.03M Sell
100,936
-4,682
-4% -$103K ﹤0.01% 1339
2023
Q3 		$2.16M Buy
105,618
+33,040
+46% +$601K ﹤0.01% 1413
2023
Q2 		$1.44M Buy
72,578
+10,637
+17% +$215K ﹤0.01% 1504
2023
Q1 		$1.06M Buy
61,941
+1,310
+2% +$25.6K ﹤0.01% 1607
2022
Q4 		$1.18M Buy
60,631
+3,192
+6% +$58.8K ﹤0.01% 1541
2022
Q3 		$841K Buy
57,439
+19,061
+50% +$297K ﹤0.01% 1685
2022
Q2 		$513K Sell
38,378
-5,258
-12% -$62.7K ﹤0.01% 2040
2022
Q1 		$694K Buy
43,636
+22,178
+103% +$383K ﹤0.01% 1975
2021
Q4 		$481 Sell
21,458
-51
-0.2% -$1.39K ﹤0.01% 2288
2021
Q3 		$643K Sell
21,509
-1,314
-6% -$47.8K ﹤0.01% 2105
2021
Q2 		$1.01M Buy
22,823
+1,422
+7% +$61.8K ﹤0.01% 1989
2021
Q1 		$950K Buy
21,401
+638
+3% +$35K ﹤0.01% 1919
2020
Q4 		$1.14M Buy
20,763
+501
+2% +$18.3K ﹤0.01% 1745
2020
Q3 		$463K Sell
20,262
-405
-2% -$9.98K ﹤0.01% 2042
2020
Q2 		$436K Buy
20,667
+283
+1% +$5.1K ﹤0.01% 2036
2020
Q1 		$284K Buy
20,384
+2,069
+11% +$41K ﹤0.01% 2124
2019
Q4 		$417K Sell
18,315
-1,014
-5% -$16.9K ﹤0.01% 2152
2019
Q3 		$226K Hold
19,329
– – ﹤0.01% 2505
2019
Q2 		$290K Buy
+19,329
New +$337K ﹤0.01% 2383
2018
Q4 		– Sell
-8,166
Closed -$201K – 2752
2018
Q3 		$201K Sell
8,166
-8,478
-51% -$184K ﹤0.01% 2767
2018
Q2 		$327K Buy
16,644
+15,558
+1,433% +$294K ﹤0.01% 2713
2018
Q1 		$20K Buy
+1,086
New +$17.7K ﹤0.01% 3753
2017
Q3 		– Sell
-200
Closed -$2K – 4317
2017
Q2 		$2K Sell
200
-1,406
-88% -$10.5K ﹤0.01% 4132
2017
Q1 		$14K Sell
1,606
-1,743
-52% -$11.7K ﹤0.01% 3599
2016
Q4 		$82K Buy
3,349
+2,116
+172% +$60.4K ﹤0.01% 3302
2016
Q3 		$47K Buy
1,233
+1,020
+479% +$32.1K ﹤0.01% 3405
2016
Q2 		$6K Hold
213
– – ﹤0.01% 3764
2016
Q1 		$6K Buy
+213
New +$6.39K ﹤0.01% 3752
2015
Q3 		– Sell
-51
Closed -$1 – 4094
2015
Q2 		$1 Buy
+51
New +$1.13K ﹤0.01% 3921

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RCKT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Rocket Pharmaceuticals (RCKT) stake by 2.6% in Q1 2026, selling an estimated $15.6K and leaving 149,204 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Manulife (Manufacturers Life Insurance) first reported a position in RCKT in Q2 2015 and has held it in 38 quarters since. The position peaked at $3.05M in Q1 2024. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 149,204 shares of Rocket Pharmaceuticals worth $534K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,917 Rocket Pharmaceuticals shares in Q1 2026, an estimated $15.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2129 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Rocket Pharmaceuticals in Q2 2015 and has held it in 38 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Rocket Pharmaceuticals position peaked at $3.05M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.